BMS-188667
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for BMS-188667, covering 2010-12-06 to 2017-01-18. Get the full timeline:
Most recent: Clinical Trial Update: BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis [Phase 3]